Bone & Joint Health #Supplements Market: Tablet Segment to Grow at the Highest CAGR by 2027

The global bone & joint health supplements market is projected to reach USD 17.6 billion by 2027, recording a CAGR of 8.5%.

Download PDF Brochure: https://www.marketsandmarkets.....com/pdfdownloadNew.a

The global bone & joint health supplements market has been influenced by some of the macroeconomic and microeconomic factors witnessed in some key countries. This would prove strong enough to drive the market significantly in terms of value.

The tablet segment is estimated to grow at the highest CAGR during the forecast period. The tablet form of bone & joint health supplements is widely consumed on account of the easy availability of various dosage patterns, easy packaging techniques, storage, and cost-effectiveness. Bone & joint health supplements in the tablet form are consumed for various nutrients such as vitamins and omega-3 fatty acids enclosed in it. Tablets are also preferred in comparison to other types of nutritional supplements due to the high shelf life associated with them.

Read more: https://www.marketsandmarkets.....com/Market-Reports/b

North America is one of the major consumers of bone & joint health supplements globally, owing to the high demand from elderly people population.

The key players in this market include Bayer AG(Germany), Procter & Gamble (US), Amway (US), Basf SE (Germany) and Archer Daniels Midland (US).